[Ip-health] 14 July 2016: - Agenda for workshop on "EU options for improving access to medicines"

Thiru Balasubramaniam thiru at keionline.org
Mon Jul 11 05:46:19 PDT 2016

*European Parliament*

*Organised by the Policy Department A*

*Economic & Scientific Policy for the Committee on the Environment, Public
Health and Food Safety (ENVI) Working Group Health*


*“EU options for improving access to medicines”*

*Thursday 14 July 2016 from 09.00 to 12.30 European Parliament, Room A3G-2
in Altiero Spinelli, Brussels*


*Chair: Ms Soledad CABEZÓN, MEP*

*Shadow rapporteur: Mr JI FARIA, MEP*

*09:00 – 09:10     *Opening and welcome

*Part 1 - Access to medicines from different points of view: Analysis of
the current situation*

*Chaired by Ms Soledad CABEZON, MEP*

*09:10 - 09:15      Pharmaceutical industry of medicines produced in Europe*

                         Mr Paul VAN HOOF, European Federation of
Pharmaceutical Industries and Associations (EFPIA)

*09:15 – 09:20     Medicines for Europe, the voice of the generic,
biosimilar and added-value medicines in Europe*

 Mr Adrian VAN DEN HOVEN, Director General, Medicines for Europe

 *09:20 – 09:25    NGOs and access to medicines*

 Dr Françoise SIVIGNON, President of Médecins du Monde, France
*09:25 – 09:30     Patient associations and access to medicines*

 Ms Kaisa IMMONEN, Director of Policy, European Patients’ Forum (EPF)

*Part 2 – Functioning analysis of pharmaceutical systems in the EU*

*Chaired by Mr José Inácio FARIA, MEP*

*09:30 – 09:40     Intellectual property law system applicable to medicine*

 Ms Ellen ’t HOEN, Medicines Law & Policy and Global Health Unit,
University Medical Centre, University of Groningen

 *09:40 – 09:50    European Systems for prices and reimbursement of

 Prof Dr Lieven ANNEMANS, Health Economics Unit, Department of Public
Health, University of Ghent

 *09:50 – 10:00    Competition enforcement for pharmaceutical products*

 Mr Dirk VAN ERPS, Head of Unit Antitrust: Pharma and Health services, DG

 *10:00 – 10:25    Questions & Answers for parts 1 and 2*

*Part 3 - Authorisation procedures and Systems for pricing and

*Chaired by Mr José Inácio FARIA, MEP*

*10:25 – 10:35      Role of EMA in authorising and supporting access to new

  Ms Enrica ALTIERI, Head of Human Medicines Evaluation, European Medicines
Agency (EMA)

 *10:35 – 10:45     Health Technology Assessment: A Perspective from

  Dr Raf MERTENS, Director of the Belgian Health Care Knowledge Centre (KCE)

 *10:45 – 10:55     Prices and affordability*

  Dr Fernando LAMATA, Expert on Health Care Policies

 *10:55 – 11:20     Question & Answers*

*Part 4 – Proposals to improve the access to medicines*

*Chaired by Soledad CABEZON, MEP*

*11:20 – 11:30     Auctions of pharmacy-dispensed drugs*

    Mr Aquilino ALONSO MIRANDA, Health Minister, Andalusian Government

*11:30 – 11:40     The role of the Innovative Medicines Initiative (IMI) in
the research, development and innovation in Medicines*

     Mr Pierre MEULIEN, Executive Director, IMI

*11:40 – 11:50     The Council Conclusions on strengthening the balance in
the pharmaceutical systems in the EU*

     Mr Ricco BUITINK – Health Attaché, Permanent Representation of the
Netherlands to the EU

 *11:50 – 12:00     The European Commission agenda on access to medicines*

  Mr Andrzej RYS, Director, Health Systems, Medical products and
innovation, DG SANTE, European Commission

 *12:00 – 12:25     Question & Answers*

 *12:25 – 12:30     Closing remarks by the Chair*

More information about the Ip-health mailing list